Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Date of authorisation: 26/06/2025, Revision: 3, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 17 September 2026 - 16:12

Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Date of authorisation: 26/06/2025, Revision: 3, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/denbrayce

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters